Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction

Qintao Ge; Zhijie Zhao; Xiao Li; Feixiang Yang; Meng Zhang; Zongyao Hao; Chaozhao Liang; Jialin Meng

doi:10.1002/ctm2.1552

Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction

Clin Transl Med. 2024 Jan;14(1):e1552. doi: 10.1002/ctm2.1552.

Authors

Qintao Ge^{1

2

3}, Zhijie Zhao⁴, Xiao Li^{1

2

3}, Feixiang Yang^{1

2

3}, Meng Zhang^{1

2

3}, Zongyao Hao^{1

2

3}, Chaozhao Liang^{1

2

3

5}, Jialin Meng^{1

2

3

5}

Affiliations

¹ Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, P. R. China.
² Institute of Urology, Anhui Medical University, Hefei, P. R. China.
³ Anhui Province Key Laboratory of Urological and Andrological Diseases Research and Medical Transformation, Anhui Medical University, Hefei, P. R. China.
⁴ Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
⁵ Anhui Provincial Institute of Translational Medicine, Hefei, P. R. China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Male
Prognosis
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / therapy
T-Lymphocytes, Regulatory*
Tumor Microenvironment

Grants and funding

202204295107020031/Anhui Province Key Project for Clinical Medical Research Translation and Advancement